Annual Total Liabilities
$61.83 M
+$57.15 M+1218.98%
31 December 2023
Summary:
Verrica Pharmaceuticals annual total liabilities is currently $61.83 million, with the most recent change of +$57.15 million (+1218.98%) on 31 December 2023. During the last 3 years, it has risen by +$20.67 million (+50.20%). VRCA annual total liabilities is now at all-time high.VRCA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$66.98 M
+$1.67 M+2.55%
30 September 2024
Summary:
Verrica Pharmaceuticals quarterly total liabilities is currently $66.98 million, with the most recent change of +$1.67 million (+2.55%) on 30 September 2024. Over the past year, it has increased by +$12.13 million (+22.12%). VRCA quarterly total liabilities is now at all-time high.VRCA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRCA Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1219.0% | +22.1% |
| 3 y3 years | +50.2% | +39.8% |
| 5 y5 years | +2396.3% | +1415.0% |
VRCA Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1219.0% | at high | +1665.8% |
| 5 y | 5 years | at high | +2396.3% | at high | +1864.7% |
| alltime | all time | at high | +2396.3% | at high | +3964.2% |
Verrica Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $66.98 M(+2.6%) |
| June 2024 | - | $65.31 M(+0.8%) |
| Mar 2024 | - | $64.80 M(+4.8%) |
| Dec 2023 | $61.83 M(+1219.0%) | $61.83 M(+12.7%) |
| Sept 2023 | - | $54.84 M(+706.4%) |
| June 2023 | - | $6.80 M(+79.3%) |
| Mar 2023 | - | $3.79 M(-19.1%) |
| Dec 2022 | $4.69 M(-90.1%) | $4.69 M(+7.0%) |
| Sept 2022 | - | $4.38 M(-90.7%) |
| June 2022 | - | $47.10 M(+2.0%) |
| Mar 2022 | - | $46.20 M(-2.8%) |
| Dec 2021 | $47.52 M | $47.52 M(-0.8%) |
| Sept 2021 | - | $47.90 M(+2.2%) |
| June 2021 | - | $46.87 M(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $46.29 M(+12.4%) |
| Dec 2020 | $41.17 M(+1107.6%) | $41.17 M(+1.0%) |
| Sept 2020 | - | $40.75 M(+5.1%) |
| June 2020 | - | $38.77 M(+2.5%) |
| Mar 2020 | - | $37.83 M(+1009.8%) |
| Dec 2019 | $3.41 M(+37.6%) | $3.41 M(-22.9%) |
| Sept 2019 | - | $4.42 M(+0.4%) |
| June 2019 | - | $4.41 M(+36.9%) |
| Mar 2019 | - | $3.22 M(+29.9%) |
| Dec 2018 | $2.48 M(-84.6%) | $2.48 M(+1.1%) |
| Sept 2018 | - | $2.45 M(-21.6%) |
| June 2018 | - | $3.13 M(+89.6%) |
| Mar 2018 | - | $1.65 M(-89.8%) |
| Dec 2017 | $16.12 M(+402.6%) | $16.12 M |
| Dec 2016 | $3.21 M | - |
FAQ
- What is Verrica Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual total liabilities year-on-year change?
- What is Verrica Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly total liabilities year-on-year change?
What is Verrica Pharmaceuticals annual total liabilities?
The current annual total liabilities of VRCA is $61.83 M
What is the all time high annual total liabilities for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual total liabilities is $61.83 M
What is Verrica Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, VRCA annual total liabilities has changed by +$57.15 M (+1218.98%)
What is Verrica Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of VRCA is $66.98 M
What is the all time high quarterly total liabilities for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly total liabilities is $66.98 M
What is Verrica Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, VRCA quarterly total liabilities has changed by +$12.13 M (+22.12%)